Edwards Lifesciences's ticker is and the CUSIP is 26176E108. A total of 1 filers reported holding Edwards Lifesciences in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,639,000 | -18.8% | 8,690 | +0.5% | 0.62% | +4.0% |
| Q4 2019 | $2,018,000 | +3.7% | 8,650 | -2.3% | 0.60% | +2.2% |
| Q3 2019 | $1,946,000 | +19.0% | 8,850 | 0.0% | 0.58% | +19.6% |
| Q2 2019 | $1,635,000 | -4.0% | 8,850 | -0.6% | 0.49% | +0.6% |
| Q1 2019 | $1,703,000 | +24.9% | 8,900 | 0.0% | 0.49% | +5.9% |
| Q4 2018 | $1,363,000 | -12.0% | 8,900 | 0.0% | 0.46% | -0.2% |
| Q3 2018 | $1,549,000 | +42.1% | 8,900 | +14.0% | 0.46% | +28.5% |
| Q1 2018 | $1,090,000 | +24.6% | 7,810 | +0.6% | 0.36% | +32.6% |
| Q4 2017 | $875,000 | – | 7,760 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaMark Advisors, LLC | 110 | $9,000 | 0.00% |